Procter Gamble Ownership
| PG Stock | USD 179.36 0.05 0.03% |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 2.5 B | Current Value 2.5 B | Avarage Shares Outstanding 2.8 B | Quarterly Volatility 218.3 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Procter |
Procter Stock Ownership Analysis
About 69.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 5.79. Procter Gamble last dividend was issued on the 18th of October 2024. The entity had 2:1 split on the 21st of June 2004. The Procter Gamble Company provides branded consumer packaged goods worldwide. The Procter Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio. Procter Gamble operates under Household Personal Products classification in the United States and is traded on New York Stock Exchange. It employs 106000 people. To find out more about Procter Gamble contact Fama Francisco at 513 983 1100 or learn more at https://www.pginvestor.com.Besides selling stocks to institutional investors, Procter Gamble also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Procter Gamble's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Procter Gamble's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Procter Gamble Quarterly Liabilities And Stockholders Equity |
|
Procter Gamble Insider Trades History
Less than 1% of Procter Gamble are currently held by insiders. Unlike Procter Gamble's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Procter Gamble's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Procter Gamble's insider trades
Procter Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Procter Gamble is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Procter Gamble backward and forwards among themselves. Procter Gamble's institutional investor refers to the entity that pools money to purchase Procter Gamble's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | T. Rowe Price Associates, Inc. | 2024-06-30 | 22.4 M | Legal & General Group Plc | 2024-06-30 | 21.6 M | Bank Of New York Mellon Corp | 2024-06-30 | 20.6 M | Franklin Resources Inc | 2024-09-30 | 20.5 M | Fisher Asset Management, Llc | 2024-09-30 | 18.4 M | Goldman Sachs Group Inc | 2024-06-30 | 17.2 M | Royal Bank Of Canada | 2024-06-30 | 16.9 M | Charles Schwab Investment Management Inc | 2024-09-30 | 16.4 M | Ameriprise Financial Inc | 2024-06-30 | 16.1 M | Vanguard Group Inc | 2024-09-30 | 228.2 M | Blackrock Inc | 2024-06-30 | 159.1 M |
Procter Gamble Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Procter Gamble insiders, such as employees or executives, is commonly permitted as long as it does not rely on Procter Gamble's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Procter Gamble insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Andre Schulten over a month ago Disposition of 1569 shares by Andre Schulten of Procter Gamble at 171.6541 subject to Rule 16b-3 | ||
Marc Pritchard over three months ago Disposition of 101704 shares by Marc Pritchard of Procter Gamble at 78.66 subject to Rule 16b-3 | ||
Susan Whaley over a year ago Procter Gamble exotic insider transaction detected | ||
Patricia Woertz over a year ago Acquisition by Patricia Woertz of 1520 shares of Procter Gamble subject to Rule 16b-3 | ||
Susan Whaley over a year ago Acquisition by Susan Whaley of 20952 shares of Procter Gamble subject to Rule 16b-3 | ||
Margaret Whitman over a year ago Procter Gamble exotic insider transaction detected | ||
Patricia Woertz over a year ago Acquisition by Patricia Woertz of 247 shares of Procter Gamble subject to Rule 16b-3 | ||
Ernesto Zedillo over a year ago Acquisition by Ernesto Zedillo of 2478 shares of Procter Gamble subject to Rule 16b-3 |
Procter Gamble's latest congressional trading
Congressional trading in companies like Procter Gamble, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Procter Gamble by those in governmental positions are based on the same information available to the general public.
| 2024-09-09 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2024-09-06 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-08-16 | Representative Kathy Manning | Acquired Under $15K | Verify | ||
| 2024-06-14 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2024-06-13 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2024-06-05 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2024-03-05 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2024-02-13 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-12-18 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2023-11-01 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-31 | Senator Markwayne Mullin | Acquired Under $15K | Verify | ||
| 2023-10-20 | Senator Pete Ricketts | Acquired $100K to $250K | Verify | ||
| 2023-09-30 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2023-09-08 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2023-06-14 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-06-07 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2023-03-06 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2022-12-06 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2022-11-03 | Representative Virginia Foxx | Acquired $50K to $100K | Verify | ||
| 2022-09-06 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2022-08-15 | Representative Debbie Dingell | Acquired Under $15K | Verify | ||
| 2022-08-05 | Representative Virginia Foxx | Acquired $50K to $100K | Verify | ||
| 2022-06-06 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2022-03-07 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2021-12-06 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2021-09-07 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2021-07-08 | Representative Katherine M Clark | Acquired Under $15K | Verify | ||
| 2021-06-30 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2021-03-08 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2020-12-07 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2020-09-08 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2020-06-03 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2020-03-04 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2020-01-23 | Senator James Inhofe | Acquired $100K to $250K | Verify | ||
| 2019-12-09 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2019-09-06 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2019-06-06 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2019-03-06 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2019-01-13 | Senator Pat Toomey | Acquired $15K to $50K | Verify | ||
| 2019-01-11 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2019-01-10 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2018-12-04 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2018-10-15 | Senator Pat Toomey | Acquired $15K to $50K | Verify | ||
| 2018-09-07 | Senator Pat Toomey | Acquired $15K to $50K | Verify | ||
| 2018-09-05 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2018-06-06 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2018-05-10 | Representative K Michael Conaway | Acquired Under $15K | Verify | ||
| 2017-12-20 | Senator Angus King | Acquired Under $15K | Verify | ||
| 2017-11-29 | Senator Pat Toomey | Acquired $15K to $50K | Verify | ||
| 2016-09-30 | Senator David Perdue | Acquired $15K to $50K | Verify | ||
| 2016-07-12 | Senator Pat Toomey | Acquired $15K to $50K | Verify | ||
| 2016-06-16 | Senator Pat Toomey | Acquired $15K to $50K | Verify | ||
| 2016-06-07 | Senator James Inhofe | Acquired $50K to $100K | Verify | ||
| 2015-06-26 | Senator David Perdue | Acquired Under $15K | Verify | ||
| 2015-05-20 | Senator Pat Toomey | Acquired $15K to $50K | Verify |
Procter Gamble Outstanding Bonds
Procter Gamble issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Procter Gamble uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Procter bonds can be classified according to their maturity, which is the date when Procter Gamble has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| PROCTER GAMBLE 645 Corp BondUS742718BH18 | View | |
| US742718AV11 Corp BondUS742718AV11 | View | |
| PROCTER GAMBLE 55 Corp BondUS742718CB39 | View | |
| PROCTER GAMBLE 555 Corp BondUS742718DF34 | View | |
| PROCTER GAMBLE 58 Corp BondUS742718DB20 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| PROCTER GAMBLE 245 Corp BondUS742718ER62 | View | |
| PROCTER GAMBLE 27 Corp BondUS742718EP07 | View |
Procter Gamble Corporate Filings
| 26th of November 2024 Other Reports | ViewVerify | |
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 30th of October 2024 Other Reports | ViewVerify | |
| 22nd of October 2024 Other Reports | ViewVerify |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Procter Gamble. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in Procter Stock please use our How to Invest in Procter Gamble guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Household Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procter Gamble. If investors know Procter will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procter Gamble listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 3.894 | Earnings Share 5.8 | Revenue Per Share 35.566 | Quarterly Revenue Growth (0.01) |
The market value of Procter Gamble is measured differently than its book value, which is the value of Procter that is recorded on the company's balance sheet. Investors also form their own opinion of Procter Gamble's value that differs from its market value or its book value, called intrinsic value, which is Procter Gamble's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procter Gamble's market value can be influenced by many factors that don't directly affect Procter Gamble's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procter Gamble's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procter Gamble is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procter Gamble's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.